Skip to content

Author

Yi-Zhen Wang

We have 2 of 12 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Aug 2026

The economic impact of opportunistic PSA screening: a real-world cost analysis from China amid evolving policy landscape.

BACKGROUND The clinical value of prostate-specific antigen (PSA) screening remains debated, and health economic evidence from real-world Chinese screening programs is lacking. This study aimed to determine whether PSA screening reduces prostate cancer treatment costs in China. RESEARCH DESIGN AND METHODS Using propen...

Zhehan Lin, Wei Li, Peng-Cheng Hu et al. · 0 citations
Open access Aug 2026

The KAT8-CDK1 K33 acetylation axis drives doxorubicin resistance by suppressing ferroptosis and apoptosis in breast cancer

KAT8-dependent CDK1 K33 acetylation is established as a key epigenetic mechanism sustaining anthracycline resistance and targeting the KAT8-CDK1 axis may provide a therapeutic strategy to overcome refractory breast cancer.

Qing-Zhi Zhao, Qi-Xian Zou, Jin-Meng Chu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.